14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 13, 2024 Sell 5 000 Lonial Sagar Common Stock
Mar 12, 2024 Sell 22 000 Charney Laurence N Common Stock
Feb 14, 2024 Buy 0 Power Sean A
Jan 06, 2024 Buy 1 001 908 Weiss Michael S Common Stock
Jan 05, 2024 Sell 17 500 Charney Laurence N Common Stock
Jan 05, 2024 Buy 75 000 Power Sean A Common Stock
Jan 03, 2024 Sell 47 867 Power Sean A Common Stock
Sep 28, 2023 Sell 20 000 Lonial Sagar Common Stock
Sep 28, 2023 Buy 20 000 Hume Daniel Common Stock
Sep 28, 2023 Buy 20 000 Hoberman Kenneth Common Stock
Sep 28, 2023 Buy 20 000 Echelard Yann Common Stock
Sep 28, 2023 Buy 20 000 Charney Laurence N Common Stock
Aug 11, 2023 Buy 100 000 Weiss Michael S COMMON STOCK
Jun 23, 2023 Sell 34 854 Lonial Sagar COMMON STOCK
Jun 02, 2023 Sell 73 647 Power Sean A COMMON STOCK
Mar 12, 2023 Buy 85 000 Power Sean A COMMON STOCK
Mar 12, 2023 Buy 985 000 Weiss Michael S COMMON STOCK
Jan 06, 2023 Buy 9 000 Echelard Yann Common Stock
Jan 04, 2023 Sell 30 000 Charney Laurence N Common Stock
Jul 20, 2022 Buy 1 900 000 Weiss Michael S Stock Option (right to buy)
Jul 20, 2022 Buy 75 000 Power Sean A Common Stock
Jul 20, 2022 Buy 200 000 Power Sean A Employee Stock Option (right to buy)
Jul 20, 2022 Buy 200 000 Power Sean A Employee Stock Option (right to buy)
Jul 20, 2022 Buy 43 732 Lonial Sagar Common Stock
Jul 20, 2022 Buy 43 732 Hume Daniel Common Stock
Jul 20, 2022 Buy 43 732 Hoberman Kenneth Common Stock
Jul 20, 2022 Buy 43 732 Echelard Yann Common Stock
Jul 20, 2022 Buy 43 732 Charney Laurence N Common Stock
Jan 05, 2022 Sell 9 653 Power Sean A COMMON STOCK
Jan 05, 2022 Sell 30 671 Weiss Michael S COMMON STOCK
Jan 04, 2022 Sell 75 312 Power Sean A COMMON STOCK
Jan 04, 2022 Sell 37 549 Weiss Michael S COMMON STOCK
Dec 29, 2021 Buy 56 394 Weiss Michael S COMMON STOCK
Dec 16, 2021 Sell 700 000 Weiss Michael S COMMON STOCK
Dec 16, 2021 Sell 9 000 Weiss Michael S COMMON STOCK
Dec 15, 2021 Sell 3 000 Weiss Michael S COMMON STOCK
Jun 18, 2021 Buy 25 000 Power Sean A COMMON STOCK
Jun 18, 2021 Buy 1 080 770 Weiss Michael S COMMON STOCK
Jun 18, 2021 Buy 20 000 Lonial Sagar COMMON STOCK
Jun 18, 2021 Buy 20 000 Hume Daniel COMMON STOCK
Jun 18, 2021 Buy 20 000 Hoberman Kenneth COMMON STOCK
Jun 18, 2021 Buy 20 000 Echelard Yann COMMON STOCK
Jun 18, 2021 Buy 40 000 Charney Laurence N COMMON STOCK
Jun 18, 2021 Buy 20 000 Charney Laurence N COMMON STOCK
Dec 31, 2020 Buy 0 Power Sean A
Dec 31, 2020 Buy 0 Weiss Michael S
Dec 30, 2020 Buy 20 000 Power Sean A COMMON STOCK
Dec 10, 2020 Sell 30 000 Echelard Yann COMMON STOCK
Sep 09, 2020 Sell 158 589 Ra Capital Management, L.p. Common Stock
Jul 16, 2020 Buy 200 000 Power Sean A COMMON STOCK
Jul 16, 2020 Buy 50 000 Power Sean A COMMON STOCK
Jun 22, 2020 Buy 65 000 Lonial Sagar COMMON STOCK
Jun 22, 2020 Buy 1 556 029 Weiss Michael S COMMON STOCK
Jun 22, 2020 Buy 15 000 Hume Daniel COMMON STOCK
Jun 22, 2020 Buy 15 000 Hoberman Kenneth COMMON STOCK
Jun 22, 2020 Buy 15 000 Echelard Yann COMMON STOCK
Jun 22, 2020 Buy 15 000 Charney Laurence N COMMON STOCK
Jun 22, 2020 Sell 15 000 Kennedy William James COMMON STOCK
Jun 17, 2020 Sell 7 745 Kennedy William James COMMON STOCK
May 05, 2020 Buy 0 Ra Capital Management, L.p. Common Stock
May 05, 2020 Buy 589 527 Ra Capital Management, L.p. Total Return Swap
Apr 24, 2020 Buy 0 Lonial Sagar
Sep 17, 2019 Buy 27 048 Hoberman Kenneth COMMON STOCK
Sep 17, 2019 Buy 27 048 Charney Laurence N COMMON STOCK
Sep 17, 2019 Buy 27 048 Echelard Yann COMMON STOCK
Sep 17, 2019 Buy 27 048 Kennedy William James COMMON STOCK
Sep 17, 2019 Buy 27 048 Hume Daniel COMMON STOCK
Jul 01, 2019 Sell 17 654 Power Sean A COMMON STOCK
Jun 26, 2019 Buy 50 000 Weiss Michael S COMMON STOCK
Jun 13, 2019 Buy 1 179 380 Weiss Michael S COMMON STOCK
Jan 02, 2019 Sell 37 275 Power Sean A COMMON STOCK
Dec 31, 2018 Buy 115 000 Power Sean A Employee Stock Option (Right to Buy)
Jul 03, 2018 Sell 35 000 Power Sean A COMMON STOCK
Jul 02, 2018 Sell 12 191 Power Sean A COMMON STOCK
Jun 26, 2018 Buy 15 000 Charney Laurence N COMMON STOCK
Jun 26, 2018 Buy 15 000 Hoberman Kenneth COMMON STOCK
Jun 26, 2018 Buy 15 000 Kennedy William James COMMON STOCK
Jun 26, 2018 Buy 1 018 011 Weiss Michael S COMMON STOCK
Jun 26, 2018 Buy 15 000 Hume Daniel COMMON STOCK
Jun 26, 2018 Buy 15 000 Echelard Yann COMMON STOCK
Jun 26, 2018 Buy 15 000 Schoenebaum Mark COMMON STOCK
Jun 14, 2018 Sell 25 071 Kennedy William James COMMON STOCK
Jan 02, 2018 Sell 32 006 Power Sean A COMMON STOCK
Dec 29, 2017 Buy 70 000 Power Sean A COMMON STOCK
Jun 19, 2017 Buy 834 877 Weiss Michael S COMMON STOCK (RESTRICTED)
Jun 19, 2017 Sell 350 000 Weiss Michael S COMMON STOCK
Jun 19, 2017 Sell 30 000 Power Sean A COMMON STOCK
Jun 16, 2017 Buy 15 000 Kennedy William James COMMON STOCK
Jun 16, 2017 Buy 15 000 Charney Laurence N COMMON STOCK
Jun 16, 2017 Buy 15 000 Hoberman Kenneth COMMON STOCK
Jun 16, 2017 Buy 15 000 Hume Daniel COMMON STOCK
Jun 16, 2017 Buy 15 000 Echelard Yann COMMON STOCK
Jun 16, 2017 Buy 15 000 Schoenebaum Mark COMMON STOCK
Jun 16, 2017 Sell 29 976 Power Sean A COMMON STOCK
Apr 11, 2017 Sell 8 548 Kennedy William James COMMON STOCK
Apr 04, 2017 Sell 7 000 Charney Laurence N Common Stock
Jan 04, 2017 Sell 8 816 Power Sean A Common Stock
Jan 01, 2017 Buy 418 371 Weiss Michael S Common Stock (Restricted)
Dec 30, 2016 Buy 100 000 Power Sean A Common Stock
Dec 30, 2016 Buy 693 750 Weiss Michael S Common Stock (Restricted)
INSIDER POWER
77.616
Last 100 transactions
Buy: 13 566 917 | Sell: 1 920 924 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 77.616.

In total, the insiders bought 13 566 917 and sold 1 920 924 TGTX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About TG Therapeutics

TG Therapeutics TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra... TGTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT